Anti-inflammatory/anti-microbial: Peptide therapy with KPV exhibits anti-inflammatory benefits partially through innate immunity, fighting two common pathogens, Staphylococcus aureus and Candida albicans
Clinical trials have demonstrated that nausea, vomiting, diarrhoea, constipation, abdominal pain, and dyspepsia are frequently reported, particularly during dose escalation
GLP-1 receptor agonists have been used successfully and safely in type 2 diabetes mellitus (T2DM) and do not induce insulin desensitization after prolonged use, as they do not activate insulin receptors in normoglycemic subjects [16] and thus do not cause hypoglycemia
With personalized care being a core focus in healthcare today, these medications offer hope for those with obesity and type 2 diabetes
Never freeze reconstituted peptide solution as this degrades the compound
Manfredo Vieira S, Hiltensperger M, Kumar V et al (2018) Translocation of a gut pathobiont drives autoimmunity in mice and humans